Costs and consequences of the Portuguese needle-exchange program in community pharmacies
- PMID: 32528601
- PMCID: PMC7265586
- DOI: 10.1177/1715163520915744
Costs and consequences of the Portuguese needle-exchange program in community pharmacies
Abstract
Background: Needle-exchange programs (NEPs) reduce infections in people who inject drugs. This study assesses the impact community pharmacies have had in the Needle-Exchange Program in Portugal since 2015.
Methods: Health gains were measured by the number of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections averted, which were estimated, in each scenario, based on a standard model in the literature, calibrated to national data. The costs per infection were taken from national literature; costs of manufacturing, logistics and incineration of injection materials were also considered. The results were presented as net costs (i.e., incremental costs of the program with community pharmacies less the costs of additional infections avoided).
Results: Considering a 5-year horizon, the Needle Exchange Program with community pharmacies would account for a 6.8% (n = 25) and a 6.5% reduction (n = 22) of HCV and HIV infections, respectively. The present value of net savings generated by the participation of community pharmacies in the program was estimated at €2,073,347. The average discounted net benefit per syringe exchanged is €3.01, already taking into account a payment to community pharmacies per needle exchanged.
Interpretation: We estimate that the participation of community pharmacies in the Needle Exchange Program will lead to a reduction of HIV and HCV infections and will generate over €2 million in savings for the health system.
Conclusions: The intervention is estimated to generate better health outcomes at lower costs, contributing to improving the efficiency of the public health system in Portugal.
© The Author(s) 2020.
Conflict of interest statement
Declaration of Conflicting Interests:This study was supported by the Portuguese National Association of Pharmacies (ANF). ANF had no control on the conduct or publication of this research. Maria Cary and José Pedro Guerreiro are researchers for the Centre for Health Research & Evaluation (CEFAR), a Contract Research Organization (CRO) of the National Association of Pharmacies (ANF), which performs health research studies. Suzete Costa was researcher and executive director of CEFAR/ANF at the time of this research. Margarida Borges, Miguel Gouveia, Francesca Fiorentino Gonçalo Jesus and António Vaz Carneiro have no competing interests to declare.
Figures
Similar articles
-
Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis.PLoS Med. 2020 Oct 13;17(10):e1003239. doi: 10.1371/journal.pmed.1003239. eCollection 2020 Oct. PLoS Med. 2020. PMID: 33048929 Free PMC article.
-
An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S126-32. doi: 10.1097/00042560-199802001-00021. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9663635
-
The role of needle exchange programs in HIV prevention.Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):75-80. Public Health Rep. 1998. PMID: 9722812 Free PMC article. Review.
-
Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange.Harm Reduct J. 2018 Jan 25;15(1):4. doi: 10.1186/s12954-018-0211-4. Harm Reduct J. 2018. PMID: 29370808 Free PMC article.
-
Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis.Addiction. 2017 Feb;112(2):236-247. doi: 10.1111/add.13593. Epub 2016 Oct 19. Addiction. 2017. PMID: 27566970 Review.
Cited by
-
Community Pharmacy Needle Exchange Programme: What Can Analysis of the Data Tell Us about the Changing Drug Market in Ireland?Int J Environ Res Public Health. 2024 Mar 1;21(3):289. doi: 10.3390/ijerph21030289. Int J Environ Res Public Health. 2024. PMID: 38541289 Free PMC article.
References
-
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug-related infectious diseases in Europe: update from the EMCDDA expert network. Luxembourg: Publications Office of the European Union; 2015.
-
- Ribeiro C, Carapinha L, Lavado E, Guerreiro C. Estimation of drug consumption of problematic/high risk. Portugal: 2012. Available: www.sicad.pt/BK/EstatisticaInvestigacao/EstudosConcluidos/Lists/SICAD_ES... (accessed Nov. 15, 2019).
-
- General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD). Annual report 2016—the situation of the country in drugs and drug addiction. Available: http://www.sicad.pt/BK/Publicacoes/Lists/SICAD_PUBLICACOES/Attachments/1... (accessed Nov. 15, 2019).
-
- Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001;15(11):1329-41. - PubMed
-
- Kimber J, Palmateer N, Hutchinson SJ, et al. Harm reduction among injecting drug users—evidence of effectiveness. In: Harm reduction: evidence, impacts and challenges EMCDDA. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction; 2010. p. 115-63. Editors: Tim Rhodes and Dagmar Hedrich.
LinkOut - more resources
Full Text Sources